# FDA Inspection 1251214 - AdventHealth Blood Center - September 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/adventhealth-blood-center/8c7f874c-e9dd-49a4-85e0-e2ed9785fcfc
Source feed: FDA_Inspections

> FDA Inspection 1251214 for AdventHealth Blood Center on September 23, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1251214
- Company Name: AdventHealth Blood Center
- Inspection Date: 2024-09-23
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1251214 - 2024-09-23](https://www.keypedia.com/records/fda_inspections/adventhealth-blood-center/149f6373-5724-4a7f-919b-5dfebff956dd)
- [FDA Inspection 1178766 - 2022-08-25](https://www.keypedia.com/records/fda_inspections/adventhealth-blood-center/9b795357-64c3-4122-a6f6-0cf49534c611)
- [FDA Inspection 1178766 - 2022-08-25](https://www.keypedia.com/records/fda_inspections/adventhealth-blood-center/251907e3-6e4a-4f68-9910-4e6a84ec5d43)

Company: https://www.keypedia.com/companies/adventhealth-blood-center/e38404d9-508e-4c81-85f1-a4365002853c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d